The COVID-19 Pandemic – Products

The Center for Emerging Viral Threats (CEVT) in Louisiana, USA, is using INTEGRA Biosciences’ liquid handling solutions for COVID-19 testing and viral genomics studies.

Meissa Vaccines announced it has entered into a manufacturing agreement with Exothera S.A. delivering customized process development and GMP manufacturing services for vaccines, viral vectors and nucleic acids.

Honeycomb Biotechnologies and Revvity have announced the launch of a suite of new solutions and services that expand the frontiers of single-cell biology.

Novice and expert in vitro diagnostics (IVD) manufacturers agree that developing, optimizing, and launching a lateral flow assay (LFA) test is never routine nor easy.

Paragraf San Diego - presented novel multiomics capabilities, by detection of both protein and RNA biosignals simultaneously on a single graphene-based biosensor.

Expert Intelligence (EI) announced at the 2023 ASMS conference in Houston, Texas its AI application builder for Mass Spectrometry analysis.

A new study has shown graphene-based biosensors could play a major role in detecting Interleukin-10 (IL-10), an important inflammation regulator, at significantly lower levels than previous point-of-care measurements.

Carterra Inc. launched its latest HT-SPR instrument, the LSAXT, at the Society for Laboratory Automation and Screening (SLAS) Conference and Exhibition in San Diego, CA.

Co-funded by Innovate UK, Aseptika is collaborating with the University of Birmingham, University of York and the National Audit of Cardiac Rehabilitation to study the impact of a hybrid delivery of cardiac rehabilitation.

MIP Discovery has announced it has secured a significant grant of funds from the Bill & Melinda Gates Foundation.